Gastroenterology
Volume 135, Issue 6 , Pages 1961-1971.e2 , December 2008

Clinical Correlates of Histopathology in Pediatric Nonalcoholic Steatohepatitis

  • Heather M. Patton

      Affiliations

    • Division of Gastroenterology, University of California, San Diego, San Diego, California
    • ,
  • Joel E. Lavine

      Affiliations

    • Division of Pediatric Gastroenterology, Hepatology, and Nutrition, University of California, San Diego, San Diego, California
    • Corresponding Author InformationAddress requests for reprints to: Joel E. Lavine, MD, PhD, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, University of California, San Diego, 200 West Arbor Drive, San Diego, California 92103-8450. fax: (619) 543-7537
    • ,
  • Mark L. Van Natta

      Affiliations

    • Data Coordinating Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
    • ,
  • Jeffrey B. Schwimmer

      Affiliations

    • Division of Pediatric Gastroenterology, Hepatology, and Nutrition, University of California, San Diego, San Diego, California
    • ,
  • David Kleiner

      Affiliations

    • Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland
    • ,
  • Jean Molleston

      Affiliations

    • Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Indiana University School of Medicine, Indianapolis, Indiana
    • ,
  • Nonalcoholic Steatohepatitis Clinical Research Network

Received 14 March 2008 ,Accepted 14 August 2008.

References 

  1. Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388–1393
  2. Brunt EM. Pathology of nonalcoholic steatohepatitis. Hepatol Res. 2005;33:68–71
  3. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:134–140
  4. Marrero JA, Fontana RJ, Su GL, et al. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 2002;36:1349–1354
  5. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–1419
  6. Ogden CL, Tabak CJ. Children and teens told by doctors that they were overweight—United States, 1999–2002. MMWR Morb Mortal Wkly Rep. 2005;54:848–849
  7. Riley MR, Bass NM, Rosenthal P, et al. Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists. J Pediatr. 2005;147:839–842
  8. Xanthakos S, Miles L, Bucuvalas J, et al. Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents. Clin Gastroenterol Hepatol. 2006;4:226–232
  9. Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42:641–649
  10. Schwimmer JB, Deutsch R, Rauch JB, et al. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr. 2003;143:500–505
  11. Lavine JE, Schwimmer JB. Nonalcoholic steatohepatitis clinical research network. Hepatology. 2003;37:244
  12. Lavine JE, Schwimmer JB. Pediatric initiatives within the Nonalcoholic Steatohepatitis-Clinical Research Network (NASH CNR). J Pediatr Gastroenterol Nutr. 2003;37:220–221
  13. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11. 2002;246:1–190
  14. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  15. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402–2410
  16. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–1321
  17. Kleiner DE, Behling CB, Brunt EM, et al. Comparison of adult and pediatric NAFLD—confirmation of a second pattern of progressive fatty liver disease in children. Hepatology. 2006;44:259A–260A
  18. Agresti A. Categorical data analysis. New York, NY: John Wiley and Sons, Inc; 1990;
  19. McCullagh P. Regression models for ordinal data. J R Statist Soc B. 1980;42:109–142
  20. StataCorp. Stata statistical software: release 10. College Station, TX: StataCorp LP; 2007;
  21. Little R, Rubin D. Statistical analysis with missing data. 2nd edition. New York, NY: John Wiley and Sons, Inc; 2002;
  22. Green D, Swets J. Signal detection theory and psychophysics. New York, NY: John Wiley and Sons, Inc; 1966;
  23. SAS. SAS, version 9.1. Cary, NC: SAS Institute Inc; 2007;
  24. Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology. 2007;133:1814–1820
  25. Homburger HA, Cahen YD, Griffiths J, et al. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods. Arch Pathol Lab Med. 1998;122:993–999
  26. Lenzi M, Bellentani S, Saccoccio G, et al. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut. 1999;45:435–441
  27. Czaja AJ, Carpenter HA, Santrach PJ, et al. Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis. J Hepatol. 1996;24:52–59
  28. Adams LA, Lindor KD, Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. Am J Gastroenterol. 2004;99:1316–1320
  29. Loria P, Lonardo A, Leonardi F, et al. Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci. 2003;48:2173–2181
  30. Yatsuji S, Hashimoto E, Kaneda H, et al. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?. J Gastroenterol. 2005;40:1130–1138
  31. Martini A, Lorini R, Zanaboni D, et al. Frequency of autoantibodies in normal children. Am J Dis Child. 1989;143:493–496
  32. Patton HM, Sirlin C, Behling C, et al. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr. 2006;43:413–427
  33. Cook JS, Hoffman RP, Stene MA, et al. Effects of maturational stage on insulin sensitivity during puberty. J Clin Endocrinol Metab. 1993;77:725–730
  34. Roemmich JN, Clark PA, Lusk M, et al. Pubertal alterations in growth and body composition (VI. Pubertal insulin resistance: relation to adiposity, body fat distribution and hormone release). Int J Obes Relat Metab Disord. 2002;26:701–709
  35. Tominaga K, Kurata JH, Chen YK, et al. Prevalence of fatty liver in Japanese children and relationship to obesity (An epidemiological ultrasonographic survey). Dig Dis Sci. 1995;40:2002–2009
  36. Guzzaloni G, Grugni G, Minocci A, et al. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord. 2000;24:772–776
  37. Manton ND, Lipsett J, Moore DJ, et al. Non-alcoholic steatohepatitis in children and adolescents. Med J Aust. 2000;173:476–479
  38. Barlow SE. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(Suppl 4):S164–S192
  39. Lackner C, Struber G, Liegl B, et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology. 2005;41:1376–1382
  40. Snyder N, Gajula L, Xiao SY, et al. APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J Clin Gastroenterol. 2006;40:535–542
  41. Bugianesi E, Manzini P, D'Antico S, et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology. 2004;39:179–187
  42. Haukeland JW, Konopski Z, Linnestad P, et al. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. Scand J Gastroenterol. 2005;40:1469–1477
  43. Angulo P, Alba LM, Petrovic LM, et al. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J Hepatol. 2004;41:943–949
  44. Richardson MM, Jonsson JR, Powell EE, et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology. 2007;133:80–90
  45. Roskams T, Yang SQ, Koteish A, et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol. 2003;163:1301–1311
  46. Roskams T. Progenitor cell involvement in cirrhotic human liver diseases: from controversy to consensus. J Hepatol. 2003;39:431–434
  47. Roskams TA, Theise ND, Balabaud C, et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology. 2004;39:1739–1745
  48. Brunt EM. Do you see what I see? (The role of quality histopathology in scientific study). Hepatology. 2008;47:771–774
  49. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128:1898–1906
  50. Merriman RB, Ferrell LD, Patti MG, et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology. 2006;44:874–880

 The authors disclose the following: The Nonalcoholic Steatohepatitis Clinical Research Network is supported by the National Institutes of Diabetes and Digestive and Kidney Diseases (grants U01DK061718, U01DK061728, U01DK061731, U01DK061732, U01DK061734, U01DK061737, U01DK061738, U01DK061730, and U01DK061713), and the National Institutes of Child Health and Human Development. Several clinical centers receive support from General Clinical Research Centers or Clinical and Translational Science Awards in conduct of Nonalcoholic Steatohepatitis Clinical Research Network studies (grants UL1RR024989, M01RR000750, M01RR00188, RR02413101, M01RR000827, UL1RR02501401, M01RR000065, and M01RR020359). This study was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute.

PII: S0016-5085(08)01549-7

doi: 10.1053/j.gastro.2008.08.050

Gastroenterology
Volume 135, Issue 6 , Pages 1961-1971.e2 , December 2008

Article Tools

* Image Usage & Resolution